Free shipping over €250 — dispatched the next business day, tracked across the EU, with a lot-matched COA.

en
ACP-105 research compound 10 mg capsules – Peptide Medix EU
  • HPLC purity ≥98%, with a COA for each lot on request
  • Certificate of analysis tied to your lot number
  • Tracked EU delivery, dispatched the next working day

SARMs

ACP-105

Non-steroidal SARM (selective androgen receptor modulator) for lab research

In stock2 formats availableCAS 899821-23-9

€55Range €55 – €68

Choose a format
Ask about this listing or request its COA
  • FormOral-format capsules in a sealed bottle with desiccant, or a 30 mL research liquid in a dropper bottle
  • Mol. weight290.79 g/mol
  • Research areasAR binding and transactivation assays, muscle and bone tissue selectivity, prostate-sparing profiles, rodent cognition and behaviour

For laboratory research use only. Sold exclusively for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, and not a medicine, food, cosmetic or dietary supplement. Terms and Conditions

Overview

Key facts

ACP-105 is a compact non-steroidal compound (CAS 899821-23-9, molecular mass around 290.8 g/mol) that emerged from selective androgen receptor modulator programmes.

CAS number
899821-23-9
Molecular weight
290.79 g/mol
Purity
≥98% by HPLC; lot-matched COA available
Form
Oral-format capsules in a sealed bottle with desiccant, or a 30 mL research liquid in a dropper bottle
Storage
Room temperature, sealed, away from light, heat and humidity; refrigeration extends liquid stability
Available sizes
10 mg · 60 capsules · 30 mL liquid · 20 mg/mL

For research use only. Not for human consumption.

ACP-105 is a compact non-steroidal compound (CAS 899821-23-9, molecular mass around 290.8 g/mol) that emerged from selective androgen receptor modulator programmes. It is neither a peptide nor a steroid: a small synthetic organic molecule with a bicyclic amine core, it engages the androgen receptor without the four-ring steroid skeleton found in testosterone and its derivatives.

What shapes its laboratory use is partial agonism. Even at saturating concentrations a partial agonist drives only a submaximal transactivation signal, and when a full agonist is present it can act as an antagonist — which makes such compounds better suited to studying receptor conformation and coregulator recruitment than to chasing the biggest response. The literature covers androgen receptor binding and transactivation assays, comparisons of tissue selectivity between muscle, bone and prostate, and rodent studies of cognition and behaviour. Limited solubility is the key practical issue: prepare stocks in DMSO or ethanol, dilute into medium, and keep the vehicle concentration identical in every well. A 30 mL solution at 20 mg/mL is offered for workflows where volumetric dilution beats repeated weighing of powder.

Specifications

Identity

CAS number
899821-23-9
Molecular weight
290.79 g/mol

Supply & purity

Form
Oral-format capsules in a sealed bottle with desiccant, or a 30 mL research liquid in a dropper bottle
Purity
≥98% by HPLC; lot-matched COA available
Available sizes
10 mg × 60 capsules; 30 mL liquid at 20 mg/mL
Solubility
Poorly water-soluble; powder stocks are typically prepared in DMSO or ethanol, and the research liquid uses a solvent carrier

Additional detail

Compound class
Non-steroidal selective androgen receptor modulator (SARM)
Molecular target
Androgen receptor (NR3C4), a nuclear hormone receptor
Reported activity
Partial agonist at the androgen receptor in reported assay work
Structural note
Compact synthetic organic molecule with a bicyclic amine core; contains no steroid ring system and no amide backbone
Research areas
AR binding and transactivation assays, muscle and bone tissue selectivity, prostate-sparing profiles, rodent cognition and behaviour
Regulatory status
Not approved by FDA or EMA for any indication; SARMs are not lawful dietary ingredients in the United States
Sport status
Prohibited at all times under the WADA anabolic agents category (S1.2)
Storage
Room temperature, sealed, away from light, heat and humidity; refrigeration extends liquid stability

Questions about ACP-105

Does ACP-105 have a peptide structure?

No. It is a small non-steroidal organic compound of about 291 g/mol with no amino acid backbone at all. It sits in the selective androgen receptor modulator class, which has no chemical relationship to the peptides we sell, even if buyers often browse the two side by side.

What distinguishes it from RAD-140 or LGD-4033?

All three bind the androgen receptor without a steroid skeleton, yet their chemistry and published pharmacology diverge. ACP-105 is considerably smaller and is reported as a partial agonist, while RAD-140 and LGD-4033 usually behave as stronger full or near-full agonists in the assays described.

What documentation confirms purity?

Every lot is HPLC-tested to a minimum of 98% and comes with a certificate of analysis for that lot, including identity confirmation. Give us the lot number on your bottle when you request it. For a compound class sold widely outside regulated channels, verifying material yourself before assays is sensible.

May ACP-105 be purchased legally?

We supply it strictly as a research chemical for laboratory work. It is not an authorised medicinal product and may not be sold as a food or supplement ingredient in the EU. Each buyer must make sure their purchase and use comply with the rules of their own jurisdiction.

Related

View category